Parkinson disease: New developments in CSF biomarkers for early detection and monitoring of Parkinson disease

被引：0
|
作者：
Yates D.
机构：
来源：
Nature Reviews Neurology | 2011年 / 7卷 / 1期
关键词：
D O I：
10.1038/nrneurol.2010.184
中图分类号：
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：1 / 1
相关论文
共 50 条
  • [1] Recent developments in biomarkers in Parkinson disease
    Schapira, Anthony H. V.
    CURRENT OPINION IN NEUROLOGY, 2013, 26 (04) : 395 - 400
  • [2] Update on CSF Biomarkers in Parkinson's Disease
    Kwon, Eun Hae
    Tennagels, Sabrina
    Gold, Ralf
    Gerwert, Klaus
    Beyer, Leon
    Toenges, Lars
    BIOMOLECULES, 2022, 12 (02)
  • [3] CSF and blood biomarkers for Parkinson's disease
    Parnetti, Lucilla
    Gaetani, Lorenzo
    Eusebi, Paolo
    Paciotti, Silvia
    Hansson, Oskar
    El-Agnaf, Omar
    Mollenhauer, Brit
    Blennow, Kaj
    Calabresi, Paolo
    LANCET NEUROLOGY, 2019, 18 (06): : 573 - 586
  • [4] CSF biomarkers and clinical progression of Parkinson disease
    Hall, Sara
    Surova, Yulia
    Ohrfelt, Annika
    Zetterberg, Henrik
    Lindqvist, Daniel
    Hansson, Oskar
    NEUROLOGY, 2015, 84 (01) : 57 - 63
  • [5] CSF biomarkers in different phenotypes of Parkinson disease
    Kurt A. Jellinger
    Journal of Neural Transmission, 2012, 119 : 455 - 456
  • [6] CSF biomarkers in different phenotypes of Parkinson disease
    Jellinger, Kurt A.
    JOURNAL OF NEURAL TRANSMISSION, 2012, 119 (04) : 455 - 456
  • [7] Increased CSF biomarkers of angiogenesis in Parkinson disease
    Janelidze, Shorena
    Lindqvist, Daniel
    Francardo, Veronica
    Hall, Sara
    Zetterberg, Henrik
    Blennow, Kaj
    Adler, Charles H.
    Beach, Thomas G.
    Serrano, Geidy E.
    van Westen, Danielle
    Londos, Elisabet
    Cenci, M. Angela
    Hansson, Oskar
    NEUROLOGY, 2015, 85 (21) : 1834 - 1842
  • [8] Longitudinal CSF biomarkers in patients with early Parkinson disease and healthy controls
    Mollenhauer, Brit
    Caspell-Garcia, Chelsea J.
    Coffey, Christopher S.
    Taylor, Peggy
    Shaw, Leslie M.
    Trojanowski, John Q.
    Singleton, Andy
    Frasier, Mark
    Marek, Kenneth
    Galasko, Douglas
    NEUROLOGY, 2017, 89 (19) : 1959 - 1969
  • [9] CSF biomarkers associated with disease heterogeneity in early Parkinson’s disease: the Parkinson’s Progression Markers Initiative study
    Ju-Hee Kang
    Brit Mollenhauer
    Christopher S. Coffey
    Jon B. Toledo
    Daniel Weintraub
    Douglas R. Galasko
    David J. Irwin
    Vivianna Van Deerlin
    Alice S. Chen-Plotkin
    Chelsea Caspell-Garcia
    Teresa Waligórska
    Peggy Taylor
    Nirali Shah
    Sarah Pan
    Pawel Zero
    Mark Frasier
    Kenneth Marek
    Karl Kieburtz
    Danna Jennings
    Caroline M. Tanner
    Tanya Simuni
    Andrew Singleton
    Arthur W. Toga
    Sohini Chowdhury
    John Q. Trojanowski
    Leslie M. Shaw
    Acta Neuropathologica, 2016, 131 : 935 - 949
  • [10] CSF biomarkers associated with disease heterogeneity in early Parkinson's disease: the Parkinson's Progression Markers Initiative study
    Kang, Ju-Hee
    Mollenhauer, Brit
    Coffey, Christopher S.
    Toledo, Jon B.
    Weintraub, Daniel
    Galasko, Douglas R.
    Irwin, David J.
    Van Deerlin, Vivianna
    Chen-Plotkin, Alice S.
    Caspell-Garcia, Chelsea
    Waligorska, Teresa
    Taylor, Peggy
    Shah, Nirali
    Pan, Sarah
    Zero, Pawel
    Frasier, Mark
    Marek, Kenneth
    Kieburtz, Karl
    Jennings, Danna
    Tanner, Caroline M.
    Simuni, Tanya
    Singleton, Andrew
    Toga, Arthur W.
    Chowdhury, Sohini
    Trojanowski, John Q.
    Shaw, Leslie M.
    ACTA NEUROPATHOLOGICA, 2016, 131 (06) : 935 - 949
12345